You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Express Scripts
Merck
Boehringer Ingelheim
Colorcon

Last Updated: February 28, 2020

DrugPatentWatch Database Preview

Patent: 8,673,631

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,673,631
Title:Chimeric regulatory sequences comprising introns for plant gene expression
Abstract: The present invention relates to a method of using a dicot intron or elements thereof to enhance transgene expression in plants. The present invention also provides constructs, transgenic plants and seeds containing the polynucleotide useful for expressing transgene in plants.
Inventor(s): Flasinski; Stanislaw (Chesterfield, MO), Hubmeier; Christopher (Ballwin, MO), Lu; Maolong (St. Louis, MO), Malven; Marianne (Ellisville, MO), Wu; Wei (St. Louis, MO)
Assignee: Monsanto Technology LLC (St. Louis, MO)
Application Number:13/280,227
Patent Claims:see list of patent claims

Details for Patent 8,673,631

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Monsanto Technology LLC (St. Louis, MO) 2026-02-17 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Monsanto Technology LLC (St. Louis, MO) 2026-02-17 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Monsanto Technology LLC (St. Louis, MO) 2026-02-17 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 8,673,631

Country Patent Number Publication Date
Canada 2637588 Aug 30, 2007
European Patent Office 1984510 Apr 08, 2015
European Patent Office 1984510 Oct 29, 2008
European Patent Office 2843053 Mar 04, 2015
United States of America 2007204367 Aug 30, 2007
United States of America 2012131694 May 24, 2012
World Intellectual Property Organization (WIPO) 2007098042 Aug 30, 2007
>Country >Patent Number >Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
McKinsey
Boehringer Ingelheim
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.